Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies

The only current strategy to test efficacy of novel interventions for sustained HIV control without antiretroviral therapy (ART) among people with HIV (PWH) is through an analytical treatment interruption (ATI). Inclusion of ‘placebo’ controls in ATIs poses ethical, logistical, and economic challeng...

Full description

Bibliographic Details
Main Authors: Gunst, JD, Gohil, J, Li, JZ, Bosch, RJ, White, Catherine Seamon, A, Chun, T, Mothe, B, Gittens, K, Praiss, L, De Scheerder, M, Vandekerckhove, L, Escandón, K, Thorkelson, A, Schacker, T, SenGupta, D, Brander, C, Papasavvas, E, Montaner, LJ, Martinez-Picado, J, Calin, R, Castagna, A, Muccini, C, de Jong, W, Leal, L, Tipoe, T, Frater, J
Format: Journal article
Language:English
Published: Nature Research 2025
_version_ 1826317179487780864
author Gunst, JD
Gohil, J
Li, JZ
Bosch, RJ
White, Catherine Seamon, A
Chun, T
Mothe, B
Gittens, K
Praiss, L
De Scheerder, M
Vandekerckhove, L
Escandón, K
Thorkelson, A
Schacker, T
SenGupta, D
Brander, C
Papasavvas, E
Montaner, LJ
Martinez-Picado, J
Calin, R
Castagna, A
Muccini, C
de Jong, W
Leal, L
Tipoe, T
Frater, J
author_facet Gunst, JD
Gohil, J
Li, JZ
Bosch, RJ
White, Catherine Seamon, A
Chun, T
Mothe, B
Gittens, K
Praiss, L
De Scheerder, M
Vandekerckhove, L
Escandón, K
Thorkelson, A
Schacker, T
SenGupta, D
Brander, C
Papasavvas, E
Montaner, LJ
Martinez-Picado, J
Calin, R
Castagna, A
Muccini, C
de Jong, W
Leal, L
Tipoe, T
Frater, J
author_sort Gunst, JD
collection OXFORD
description The only current strategy to test efficacy of novel interventions for sustained HIV control without antiretroviral therapy (ART) among people with HIV (PWH) is through an analytical treatment interruption (ATI). Inclusion of ‘placebo’ controls in ATIs poses ethical, logistical, and economic challenges. To understand viral dynamics and rates of post-treatment control (PTC) after ATI among PWH receiving either placebo or no intervention, we undertook an individual-participant data meta-analysis. In total, 24 eligible prospective studies with 382 individuals with ≥5 plasma HIV RNA viral loads (pVLs) within the first 84 days post-ATI were included. Early-ART was defined as ART initiation within 6 months of HIV acquisition; others were classified as late-ART or unknown. Median age was 42 years, 91% male, 75% white, 45% received early-ART. Median time to pVL >50, >400, and >10,000 copies/mL was 16 days (interquartile range [IQR]:13–25), 21 (IQR:15–28), and 32 (IQR:20–35), respectively. PTC defined as pVL <50 copies/mL at day 84 occurred in 4% (n = 14) of participants (6% early-ART and 1% late-ART). Sustained PTC of pVL <50 copies/ml after 84 days is rare in PWH, especially in those starting ART late. Our findings inform future interventional HIV cure/remission trials on study size and design.
first_indexed 2025-02-19T04:35:57Z
format Journal article
id oxford-uuid:31b64f5c-043c-40cd-bcdb-ff8c764f475f
institution University of Oxford
language English
last_indexed 2025-02-19T04:35:57Z
publishDate 2025
publisher Nature Research
record_format dspace
spelling oxford-uuid:31b64f5c-043c-40cd-bcdb-ff8c764f475f2025-01-30T20:03:52ZTime to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studiesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:31b64f5c-043c-40cd-bcdb-ff8c764f475fEnglishJisc Publications RouterNature Research2025Gunst, JDGohil, JLi, JZBosch, RJWhite, Catherine Seamon, AChun, TMothe, BGittens, KPraiss, LDe Scheerder, MVandekerckhove, LEscandón, KThorkelson, ASchacker, TSenGupta, DBrander, CPapasavvas, EMontaner, LJMartinez-Picado, JCalin, RCastagna, AMuccini, Cde Jong, WLeal, LTipoe, TFrater, JThe only current strategy to test efficacy of novel interventions for sustained HIV control without antiretroviral therapy (ART) among people with HIV (PWH) is through an analytical treatment interruption (ATI). Inclusion of ‘placebo’ controls in ATIs poses ethical, logistical, and economic challenges. To understand viral dynamics and rates of post-treatment control (PTC) after ATI among PWH receiving either placebo or no intervention, we undertook an individual-participant data meta-analysis. In total, 24 eligible prospective studies with 382 individuals with ≥5 plasma HIV RNA viral loads (pVLs) within the first 84 days post-ATI were included. Early-ART was defined as ART initiation within 6 months of HIV acquisition; others were classified as late-ART or unknown. Median age was 42 years, 91% male, 75% white, 45% received early-ART. Median time to pVL >50, >400, and >10,000 copies/mL was 16 days (interquartile range [IQR]:13–25), 21 (IQR:15–28), and 32 (IQR:20–35), respectively. PTC defined as pVL <50 copies/mL at day 84 occurred in 4% (n = 14) of participants (6% early-ART and 1% late-ART). Sustained PTC of pVL <50 copies/ml after 84 days is rare in PWH, especially in those starting ART late. Our findings inform future interventional HIV cure/remission trials on study size and design.
spellingShingle Gunst, JD
Gohil, J
Li, JZ
Bosch, RJ
White, Catherine Seamon, A
Chun, T
Mothe, B
Gittens, K
Praiss, L
De Scheerder, M
Vandekerckhove, L
Escandón, K
Thorkelson, A
Schacker, T
SenGupta, D
Brander, C
Papasavvas, E
Montaner, LJ
Martinez-Picado, J
Calin, R
Castagna, A
Muccini, C
de Jong, W
Leal, L
Tipoe, T
Frater, J
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
title Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
title_full Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
title_fullStr Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
title_full_unstemmed Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
title_short Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
title_sort time to hiv viral rebound and frequency of post treatment control after analytical interruption of antiretroviral therapy an individual data based meta analysis of 24 prospective studies
work_keys_str_mv AT gunstjd timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT gohilj timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT lijz timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT boschrj timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT whitecatherineseamona timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT chunt timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT motheb timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT gittensk timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT praissl timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT descheerderm timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT vandekerckhovel timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT escandonk timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT thorkelsona timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT schackert timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT senguptad timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT branderc timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT papasavvase timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT montanerlj timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT martinezpicadoj timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT calinr timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT castagnaa timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT muccinic timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT dejongw timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT leall timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT tipoet timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies
AT fraterj timetohivviralreboundandfrequencyofposttreatmentcontrolafteranalyticalinterruptionofantiretroviraltherapyanindividualdatabasedmetaanalysisof24prospectivestudies